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SUMMARY 
Fibrodysplasia Ossificans Progressiva is a rare debilitating disorder of the musculoskeletal system affecting one in 
two million individuals. It is characterized by progressive extraskeletal ossification of soft tissues resulting in the 
original skeleton being encased in unyielding new bone leading to disability and ultimately death from cardi-
orespiratory failure. The present case brings to light the delays and potential pitfalls in diagnosis as a result of the 
rarity of the condition. 
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INTRODUCTION 
Fibrodysplasia Ossificans Progressiva (Munchmeyer's 
disease, stoneman's disease, Myositis Ossificans Pro-
gressiva) first described by Guy Patin in 1692,1,2 is a 
rare progressively disabling disease characterized by 
congenital malformations of the great toes and ex-
traskeletal bone formation that gradually encases the 
original skeleton resulting in restriction of movement 
and eventual immobility and mortality from cardi-
orespiratory complications around the fourth decade of 
life.1,3 
 
It is extremely rare with an incidence of one in two mil-
lion individuals occurring without bias to gender, race 
or ethnicity.4 It is an autosomal dominant disorder with 
most patients having a spontaneous new mutation of a 
bone morphogenic protein type 1 receptor (ACVR1) 
which results in activation of osteogenesis in ectopic 
sites without ligand binding.5,6 Familial cases have also 
been reported.7     
 
Individuals are born usually following an uneventful 
gestation but the great toe abnormalities are almost in-
variably present at birth.2,4 These include hallux valgus, 
shortened great toes and sharpening of the first metatar-
sal bone.8 In the first decade of life, intermittent epi-
sodes of painful soft tissue swellings occur which pro-
gress to become the hard, bony lesions that characterize 
the disease. Biopsy reveals endochondral bone for-
mation in ectopic sites but predictably leads to worsen-
ing of the condition with explosive new bone formation 
and calcification as has been seen in individuals who 
have inadvertently had a biopsy.  
Early diagnosis slows progression of the disease and 
crucially helps to avoid biopsies or procedures that re-
sult in florid exacerbations.9 
 
CASE REPORT 
A nine-year-old boy presented with a five year history 
of multiple neck and back swellings. He was the product 
of a normal term pregnancy with non-consanguineous 
parents and no other member of his extended family had 
similar swellings. 
 
Clinical records reveal that at the age of four, he was 
diagnosed with probable spinal tuberculosis but didn't 
undergo treatment because there wasn't additional sup-
porting clinical or laboratory evidence. 
 
At the age of six, he was managed as a case of multiple 
exostoses and was treated non-operatively but was sub-
sequently lost to follow-up. 
 
He re-presented at the age of nine with neck swelling, 
stiffness, pain and numerous bony swellings over the 
occiput, the posterior neck, parascapular and thoraco-
lumbar paraspinal regions.(Figures 1A and 1B) Further 
examination revealed bilateral big toe malformations 
(hallux valgus)  that had been present since birth but 
wasn't of concern to the patient nor his parents.(Figure 
3) Radiographs revealed extra skeletal ossification of 
the soft tissues of the posterior neck, para scapular-
thoracolumbar regions and confirmed bilateral hallux 





                                                                                                                                                                               
 
 
                                                                                                                                                                               


































































Figure 1A Bony swell-
ings over back and neck 
Figure 1B Similar swellings 
in thoracic region 
Figure 2A Paraspinal soft 
tissue ossification 
Figure 2B Extra skeletal soft 
tissue ossification in the neck 
Figure 3 Hallux val-
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The family was advised against a biopsy or excision of 
the lesions. Analgesics and oral prednisolone were giv-
en for the period of the flare-up with resolution of the 
acute symptoms after three weeks and he is presently 
able to attend school regularly. 
 
The patient and his parents were counseled regarding 
the cause, course and prognosis of the disease and the 
availability of support groups like the International Fi-




Fibrodysplasia ossificans progressiva (FOP) is a rare 
disease with peculiar phenotypic features of extraskele-
tal new bone formation and great toe abnormalities. It is 
unsurprising the diagnosis wasn't made in this patient 
until the fifth year after initial presentation. 
 
 A survey from five continents by Kitterman et al 
showed erroneous diagnoses in about 90% with 67% of 
patients being subjected to potentially harmful invasive 
diagnostic procedures.4,7-10 Awareness across a wide 
spectrum of practitioners is key to early diagnosis and 
prevention of injurious diagnostic or therapeutic inter-
ventions. Although it is a rare disease, the clinical fea-
tures are unique and unambiguous and genetic testing 
has recently become available.2,5 
 
A biopsy is contraindicated due to risk of catastrophic 
explosive new bone formation.2,10,11 Disease flare-ups 
may be precipitated by trauma including intramuscular 
injections, lesion biopsies and nerve blocks especially 
around the temporomandibular joint.4,10-13 
 
There is presently no cure for the disease. A multitude 
of therapeutic agents have been tried without success 
but some selected agents like palovarotene currently 
undergoing clinical trials have shown some promise.14-16  
 
Currently analgesia with non-steroidal anti-
inflammatory drugs and a short course of steroids start-
ed at the onset of a flare-up are the mainstay of treat-
ment during "flare-ups."2 
 
Support groups such as IFOPA offer up to date advice 
and invaluable information concerning the disease. 
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